© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Vascular function in preeclampsia
aDepartment of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, The Netherlands
bDepartment of Medical Physics, Academic Medical Center, Amsterdam, The Netherlands
cDepartment of Obstetrics and Gynaecology, Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden
* Corresponding author. Tel.: +31-20-566-9111; fax: +31-20-696-3489 m.j.vanwijk{at}amc.uva.nl
Preeclampsia is a multisystem disorder peculiar to human pregnancy. It occurs in 4–5% of all pregnancies and remains a leading cause of maternal and neonatal mortality and morbidity. The pathophysiology of this syndrome is not fully understood. Two stages of vascular dysfunction seem to be involved. In the early stage suboptimal development of the placenta and a hemodynamic maladaptation to pregnancy exist. At this stage maternal constitutional factors such as genetic and immunological factors and pre-existing vascular diseases may play a role. Due to this defective placentation a factor is released from the placenta, supposedly under the influence of ischemia. This factor then results in the late vascular dysfunction characterised mainly by a generalised endothelial dysfunction, leading to the clinical syndrome of preeclampsia. This review attempts to unravel the mechanisms that may contribute to preeclampsia-associated changes in vascular function and to indicate the research needed to improve our understanding of this disease.
KEYWORDS Hypertension; Hemodynamics; Endothelial function; Arteries; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Meziani, A. Tesse, E. David, M. C. Martinez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular Contractility Am. J. Pathol., October 1, 2006; 169(4): 1473 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pridjian, C. Pridjian, S. Danchuk, M. Ianosi-Irimie, H. V. Vu, and J. B. Puschett Beneficial Effects of Metolazone in a Rat Model of Preeclampsia J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1027 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.M. Page, J. Dakour, and D.W. Morrish Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia Mol. Hum. Reprod., July 1, 2006; 12(7): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-A. Wathen, E. Tuutti, U.-H. Stenman, H. Alfthan, E. Halmesmaki, P. Finne, O. Ylikorkala, and P. Vuorela Maternal Serum-Soluble Vascular Endothelial Growth Factor Receptor-1 in Early Pregnancy Ending in Preeclampsia or Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 180 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Cowden Dahl, B. H. Fryer, F. A. Mack, V. Compernolle, E. Maltepe, D. M. Adelman, P. Carmeliet, and M. C. Simon Hypoxia-Inducible Factors 1{alpha} and 2{alpha} Regulate Trophoblast Differentiation Mol. Cell. Biol., December 1, 2005; 25(23): 10479 - 10491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Cowden Dahl, S. E. Robertson, V. M. Weaver, and M. C. Simon Hypoxia-inducible Factor Regulates {alpha}v{beta}3 Integrin Cell Surface Expression Mol. Biol. Cell, April 1, 2005; 16(4): 1901 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Anderson, F. Lopez, H.-Y. Zhang, K. Pavlish, and J. N. Benoit Reduced Uteroplacental Perfusion Alters Uterine Arcuate Artery Function in the Pregnant Sprague-Dawley Rat Biol Reprod, March 1, 2005; 72(3): 762 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Donker, S. A. Asgeirsdottir, F. Gerbens, M. G. van Pampus, C. G. M. Kallenberg, G. J. t. Meerman, J. G. Aarnoudse, and G. Molema Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro Reproductive Sciences, February 1, 2005; 12(2): 98 - 106. [Abstract] [PDF]
|
|
|
|
|
|
E. Maioli, V. Fortino, and A. Pacini Parathyroid Hormone-Related Protein in Preeclampsia: A Linkage Between Maternal and Fetal Failures Biol Reprod, December 1, 2004; 71(6): 1779 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Luksha, H. Nisell, and K. Kublickiene The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1102 - R1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Liu, M. J. Percy, C. I. Amos, Y. Guan, S. Shete, D. W. Stockton, M. F. McMullin, L. A. Polyakova, S. O. Ang, Y. D. Pastore, et al. The worldwide distribution of the VHL 598C>T mutation indicates a single founding event Blood, March 1, 2004; 103(5): 1937 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hirtenlehner, J. Pollheimer, C. Lichtenberger, M. F. Wolschek, H. Zeisler, P. Husslein, and M. Knofler Elevated Serum Concentrations of the Angiogenesis Inhibitor Endostatin in Preeclamptic Women Reproductive Sciences, October 1, 2003; 10(7): 412 - 417. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Mateev, A. H. Sillau, R. Mouser, R. E. McCullough, M. M. White, D. A. Young, and L. G. Moore Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H820 - H829. [Abstract] [Full Text] [PDF]
|
|